Synonyms:
Status: Phase 3
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: Z26P56GFTV

Structure

InChI Key QCVNMNYRNIMDKV-UHFFFAOYSA-N
Smile O=C1CC2(C(=O)N1)C(=O)N(Cc1ccc(Br)cc1F)C(=O)c1cccn12
InChI
InChI=1S/C17H11BrFN3O4/c18-10-4-3-9(11(19)6-10)8-21-14(24)12-2-1-5-22(12)17(16(21)26)7-13(23)20-15(17)25/h1-6H,7-8H2,(H,20,23,25)

Physicochemical Descriptors

Property Name Value
Molecular Formula C17H11BrFN3O4
Molecular Weight 420.19
AlogP 1.31
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 2.0
Polar Surface Area 88.48
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 26.0

Pharmacology

Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Oxidoreductase
- 15 - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Diabetic Neuropathies 3 D003929 ClinicalTrials
Polyneuropathies 2 D011115 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
CAS NUMBER 147254-64-6
ChEMBL CHEMBL334830
DrugBank DB05327
EPA CompTox DTXSID80163642
FDA SRS Z26P56GFTV
PubChem 153948
SureChEMBL SCHEMBL498993
ZINC ZINC000000598422